To evaluate the outcome of treatment for deep sternal wound infection (DSWI) in a nationwide patient cohort, before and after the introduction of negative-pressure wound therapy (NPWT). 
INTRODUCTION
Deep sternal wound infection (DSWI) following open-heart surgery is a serious and devastating complication, with an incidence between 1 and 5% in most studies [1, 2] . After conventional treatment (CvT), which usually involves surgical revision followed by open wound dressings with or without wound irrigation, mortality of up to 24% has been reported [2, 3] . Furthermore, DSWI is associated with significantly increased morbidity and costs [4] , and negative effect on long-term quality of life [5] .
Early and aggressive treatment is the key to effective treatment. However, negative-pressure wound therapy (NPWT) has been shown to have several advantages over CvT, including lower in-hospital mortality, improved wound healing and shorter length of stay (LOS) [2, 3] . Several studies have compared early outcome of NPWT with that of CvT, but in most of these reports, information on failure rate, including the need for surgical intervention for re-infections, is missing. However, most of these studies have involved large tertiary reference centres and thus, the outcome of NPWT treatment may not be representative of the general population. NPWT was introduced in Iceland in August 2005 as a first-line therapy for DSWI following open heart surgery and, subsequently, all patients with DSWI in Iceland have been treated with NPWT.
We evaluated the outcome of DSWI in Iceland, using a population-based registry of all cardiothoracic operations in the country, before and after the introduction of NPWT. Our main interest was early and late outcome and the need for surgical intervention due to early re-infections.
MATERIALS AND METHODS
Landspitali University Hospital is a 750-bed teaching hospital in Reykjavik, Iceland, the only centre performing cardiac surgery in the country. During the period 1 January 2000 and 31 December 2010, 43 adults (>18 years) were diagnosed as having culture-verified DSWI following open heart surgery. The National Bioethics Committee and the Icelandic Data Protection Commission approved the study protocol.
DSWI was defined according to the guidelines from the US Centers for Disease Control and Prevention (CDC) for poststernotomy mediastinitis [6] . An early re-infection was defined as an infection fulfilling the CDC definition of DSWI that was diagnosed after at least one adequate treatment attempt. Late chronic infections were defined as infections of the sternum that required surgical intervention, but did not fulfil the criteria for DSWI, and that were diagnosed after discharge from hospital. Examples of late infections include sternocutaneous fistulas, subcutaneous abscesses, and chronic osteomyelitis. All infections were culture verified.
All patients with DSWI were initially treated with intravenous antibiotics, surgical debridement of necrotic and infected tissue, and the removal of sternal wires. The patients were divided into two study groups according to the primary treatment used after wound debridement (CvT or NPWT).
The CvT group consisted of 23 patients who were treated between January 2000 and July 2005 with either open dressings and/or closed irrigation. Open wound dressing treatment consisted of packing of the wound with either paraffin or chlorhexidine gauze dressings that were changed twice daily, until delayed primary closure could be achieved or the skin could be sutured together to bring the edges of the wound together. When closed irrigation was performed, two to three chest tubes were placed in the mediastinum and irrigated with 0.9% saline, the chest tubes being removed when the wound was no longer considered to be infected.
The NPWT group included 20 consecutive patients who were treated after August 2005. In all cases, NPWT was used as a firstline therapy. Following wound debridement, a paraffin gauze dressing was placed at the bottom of the wound to protect the right ventricle. Subsequently, polyurethane foam was placed in the wound in two layers (V.A.C.® GranuFoam™; KCI Medical, San Antonio, TX, USA). A negative pressure of −125 mmHg was applied using the vacuum-assisted closure system (V.A.C.®; KCI Medical). After 2-4 days, the wound was reopened and the foam changed, most often for a total of three times. When the wound was granulated and there was no sign of infection, delayed primary closure was performed-or secondary closure when necessary.
Outcome variables were the rate of early re-infections and chronic sternal infections, LOS, in-hospital mortality and 1-year survival.
All patients were followed up 1 week postoperatively by the surgical team and four times annually by their consultant cardiologist. All patients with complications were treated at our institution, but 2 patients left the country within 1 year after the operation. On 1 April 2011, the total length of follow-up was 168 person-years with an average follow-up time of 3.9 ± 3.1 years (range 0.1-10.8). In the CvT group, total follow-up was 123 person-years (average 5.4 ± 3.5 years, range 0.1-10.8) and it was 45 person-years (average 2.2 ± 1.2 years, range 0.4-4.3) in the NPWT group.
Continuous variables were compared using Student's unpaired t-test with approximately normally distributed data, otherwise a Wilcoxon-Mann-Whitney U-test was used. Categorical variables were compared using χ 2 test or Fisher's exact test. Outcome variables with censored data were compared using a log-rank test. Logistic regression analysis was used to calculate odds ratio and 95% confidence interval for recurrence of DSWI after treatment with either CvT or NPWT, thereby adjusting for known risk factors of DSWI, especially peripheral arterial disease and different pathogens. Statistical analysis was performed and graphs were plotted using the STATA software version 10. Two-tailed P values less than 0.05 were considered significant. One-year crude survival was plotted using the Kaplan-Meier method.
RESULTS
During the 11-year study period, 43 of 2446 open heart surgery patients (1.8%) were diagnosed with DSWI in Iceland. Mean age for the whole group of patients was 69 years and 74% were males. In both groups, coronary artery by-pass grafting (CABG) alone was the most common procedure (63%), followed by aortic valve replacement in combination with CABG (16%), and aortic valve replacement alone (7%). The left internal mammary artery was used as a bypass conduit in 20 cases (87%) in the CvT group compared with 15 (75%) in the NPWT group (P = 0.31). An emergency operation was performed in 2 cases (5%), and there was bilateral use of the internal mammary arteries in three (7%).
Preoperative characteristics in the CvT and NPWT groups are presented in Table 1 . There were no significant differences between the groups except for peripheral artery disease, 
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Coagulase-negative staphylococci were identified as sole pathogen in the CvT group in 7 cases (30%) when compared with 14 (70%) in the NPWT group (P = 0.01). Staphylococcus aureus was the only pathogen identified in 10 patients (43%) in the CvT group and in 4 patients (20%) in the NPWT group (P = 0.10).
Other pathogens or multiple pathogens were identified in 6 patients (26%) in the CvT group and in 2 patients in the NPWT group (P = 0.18). The surgical outcome for both groups is presented in Table 2 . There was no significant difference in LOS stay between the CvT and NPWT groups: 48 ± 23 days (median 43, inter-quartile range 32-60) and 47 ± 17 days (median 43, inter-quartile range 34-60), respectively (P = 0.84). The same was true for ICU stay, 4.3 ± 7.4 days (median 1, inter-quartile range 0-5) when compared with 3.7 ± 7.6 days (median 1, inter-quartile range 0-4) for the CvT and NPWT groups, respectively (P = 0.81). One patient in the CvT group died during treatment, whereas none died in the NPWT group.
Early re-infection was diagnosed in 9 patients (21%), 8 (35%) in the CvT group and one (5%) in the NPWT group (P = 0.02) ( Table 3 ). The time from the primary operation to surgical treatment for re-infection was 47 ± 41 days (median 35; inter-quartile range 24-48). In the CvT group, 5 patients had originally been treated with closed irrigation and three with open wound dressing. The only patient with persistent DSWI in the NPWT group was found to have a Pseudomonas aeruginosa infection, which was cultured from both the wound and the sponge. NPWT treatment was discontinued and acetic acid wound dressing used successfully, which made rewiring of the sternum, without tissue flap surgery, possible.
Late chronic sternal wound infections requiring surgical treatment developed in 1 patient in the NPWT group and in 6 patients in the CvT group (including 3 patients who were treated for persistent DSWI), but the difference was not statistically significant (P = 0.10). The same was true for 1-year survival in the two groups (Fig. 1 ).
There were three intraoperative complications. In the NPWT group, a bleeding from the heart that was not life-threatening occurred in 2 cases, but there was no complete rupture of the right ventricle. In both cases, direct suture with patch was performed without the need for cardiopulmonary by-pass. In the CvT group, 1 patient with a recurrent DSWI had a rupture of the right ventricle when the sternal wound was reopened, which resulted in a fatal intraoperative bleeding. 
DISCUSSION
This study shows that DSWI treated with NPWT is associated with a significantly lower rate of early re-infections requiring surgical revision. The rate of early re-infections in the CvT group and in the NPWT group corresponds well with other reports of comparison of NPWT and CvT, most of them showing around 25% lower absolute risk of re-infections following NPWT [3, 7, 8] . Not all studies have shown a lower rate of surgical reintervention following NPWT for DSWI [9] . Bapat et al. (2008) reported that patients treated with long-term NPWT had a higher risk of recurrence than those with primary closure [10] . In these studies, NPWT was used as the only treatment and no primary closure of the wound was performed. In our opinion, one of the major strengths of NPWT is the facilitation of delayed primary closure, as the sternum and adjacent tissue are well preserved. Although coagulase-negative staphylococci were more common in the NPWT group, the risk of early re-infections could not be related to that finding exclusively. This is important as these pathogens may not be as aggressive as pathogens such as S. aureus in this setting. Furthermore, the rate of methicillin-resistant S. aureus infections in Iceland has been low and has remained low throughout the period [11] .
Late chronic infections of the sternum can arise both as primary infections and following DSWI, and often result in numerous surgical procedures [12] . Although the difference was not statistically significant, there appeared to be a trend of fewer late infections following NPWT (Table 2) . Previous studies have shown that up to 90% of these infections are diagnosed within the first year, and the effect of a shorter follow-up in the NPWT group should therefore be minimal [12] .
There was not a significant difference in the LOS between groups. There are conflicting results regarding LOS following NPWT, some studies suggesting shorter LOS [7] while other studies similar [3, 8] .
One in-hospital death occurred in the CvT group when compared with none in the NPWT group. Our results suggest that early and late mortality following both CvT and NPWT for DSWI is low [1] . Several recent reports have shown that NPWT is associated with low DSWI mortality, both early (as low as 1.1%) and late [2, 13, 14] . This is important, since early mortality as high as 24% following CvT has been reported [2, 3] . However, there may be other explanations for this reduced mortality after treatment for DSWI, e.g. improved intensive care or sepsis treatment.
Significant bleeding from the wound occurred in 3 cases (7%). This is a known complication of both DSWI and NPWT, which might be prevented in most cases with careful surgical techniques [14] .
To the best of our knowledge, this is the first study to compare historically CvT and NPWT in a nationwide cohort of patients, thus minimizing the effects of referral bias on the outcome of treatment. We believe that further studies of failure rate and mortality rate in larger patient cohorts are warranted.
Limitations
The most important limitation of the study is that the groups were relatively small, which may have an effect on the analysis regarding both operative mortality and hospital stay.
Conclusion
NPWT seems to significantly reduce the risk of early re-infections in patients with DSWI. We think NPWT should be considered as a first-line treatment for most DSWIs. 
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S. Steingrimsson et al. / Interactive CardioVascular and Thoracic Surgery
We read with great interest the article by Steingrimsson et al. regarding the efficiency of vacuum-assisted closure (VAC) therapy for deep sternal wound infections (DSWI) in cardiac surgery [1] . The definition of DSWI as documented by the US Centers for Disease Control is an 'infection involving fascia or deeper with at least one of the following: evidence of infection seen at re-operation or spontaneous dehiscence, positive culture of mediastinal fluid and/or positive blood culture and/ or chest pain with sternal instability and temperature higher than 38°C [2] . ' VAC therapy has now become a standard method of treatment for DSWI. In a prospective randomized trial by Moues and colleagues in 2004, a significant reduction in the wound surface area was noted in the VAC group compared to the conventional moist gauze therapy [3.8 ± 0.5 percent/day (mean ± SEM) vs 1.7 ± 0.6 percent/day respectively; p < 0.05]. However, the superiority of VAC therapy could not be explained by a significant reduction in the bacterial load [3] .
In the retrospective cohort study by Gdalevitch and colleagues, the predictive factors identified for VAC treatment failure were the positive blood cultures (most sensitive predictor), wound depth of more than 4 cm (most specific predictor) and a high degree of sternal exposure and instability. Furthermore, the authors have suggested that these patients might be better managed by a surgical approach [4] .
Luckraz and colleagues, in 2003, suggested that VAC therapy used alone or combined with other surgical modalities can offer acceptable results for the treatment of DSWI in cardiac surgery. In addition, the total cost for the hospitalization and treatment for patients in the VAC group was $16 400 per patient, compared with $20 000 per patient in the sternal rewiring and closed irrigation treatment group [5] .
In conclusion, VAC therapy is an acceptable method for the treatment of DSWI. Patients with these devastating and potentially life-threatening complications can be assessed on an individual basis by an experienced team of cardiothoracic surgeons.
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